• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

Brainstorm Health: CEOs Behind Closed Doors, Alzheimer’s Drug Fails, Graham Cassidy Struggles

By
Sy Mukherjee
Sy Mukherjee
and
Clifton Leaf
Clifton Leaf
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
and
Clifton Leaf
Clifton Leaf
Down Arrow Button Icon
September 26, 2017, 1:30 PM ET

Happy Tuesday, Dailies. Fortune and Time gathered 100 global chief executives yesterday in lower Manhattan for a day of powerful conversations about how the private sector can do well by doing good—which, as Fortune subscribers know, is the theme of our annual Change the World issue. (If you’re not already a subscriber, please consider becoming one now: CLICK HERE. Your subscriptions enable us to keep bringing you the in-depth business journalism that our 87-year-old magazine is celebrated for—and also lets us keep offering this nifty *free* daily newsletter along with the five others we publish. Thank you!)

And after you sign up for a Fortune subscription (thank you!), you can feel utterly guiltless about viewing our CEO Initiative plenary sessions live in the comfort of your own living room/office.

The day began with me talking with JPMorgan Chase CEO Jamie Dimon about that company’s surprising (and promising) investment in rebuilding Detroit and ended with provocative conversations with UN Secretary General António Guterres and Ohio Governor John Kasich.

For a selection of coverage of yesterday’s event —yes, more *free* stuff!—click on the Fortune.com links below.

Jamie Dimon, CEO, JPMorgan Chase:

https://fortune.com/2017/09/25/jamie-dimon-detroit-jp-morgan/

Indra Nooyi, CEO, Pepsico, and Mark Bertolini, CEO, Aetna:

https://fortune.com/2017/09/25/indra-nooyi-pepsi-mark-bertolini-aetna/

Tom Wilson, CEO, Allstate:

https://fortune.com/2017/09/25/insurance-allstate-ceo-initiative/

Raj Panjabi, CEO, Last Mile Health:

https://fortune.com/2017/09/25/health-care-technology-ceo-initiative/

Arianna Huffington, CEO, Thrive Global and member, board of directors, at Uber:

https://fortune.com/2017/09/25/arianna-huffington-uber-culture/

Brian Krzanich, CEO, Intel:

https://fortune.com/2017/09/25/brian-krzanich-andy-grove-intel/

UN Secretary General António Guterres:

https://fortune.com/2017/09/25/un-secretary-general-antionio-guterres-gender-equality/

Ohio Governor John Kasich:

https://fortune.com/2017/09/25/ohio-governor-john-kasich-talks-ceos-amazon-and-education/

In other news, Kaiser Permanente CEO Bernard Tyson (that’s him sitting next to Krzanich in the video above) dropped by the office for a visit this morning. We had a great talk about his vision for a health care realm that he believes can be “both high-tech and high-touch.” I’ll share some of his insights with you tomorrow.

Clifton Leaf, Editor in Chief, FORTUNE
@CliftonLeaf
clifton.leaf@fortune.com

DIGITAL HEALTH

Patient in vegetative state partially revived by nerve stimulation. Medical experts are urging caution and restraint after a man who's been in a persistent vegetative state for 15 years achieved a "minimally conscious" state after low-intensity nerve stimulation in the brain. Some doctors have responded skeptically about whether or not the procedure actually worked as advertised, but the study authors say it's a type of therapy worth exploring. (Science)

INDICATIONS

Another Alzheimer's drug hopeful bites the dust. Another day, another heartbreak in the Alzheimer's drug development space. Biotech Axovant, part of the ambitious Roivant Sciences family of drug companies, saw its stock sink more than 71% in Tuesday trading after it announced that the experimental treatment intepirdine didn't meet the main goal in a late study of mild-to-moderate Alzheimer's patients. "Patients and physicians have witnessed an unrelenting series of failures in Alzheimer’s disease trials over the past decade and a half. Regrettably this is one more to add to the list, but the contributions of the trial participants were not in vain: researchers will generate valuable information from the trial that we hope will improve future trials in this area," the company said in a statement. (Reuters)

Hurricane Maria hits drug production in Puerto Rico. FDA Commissioner Scott Gottlieb is warning that the devastation wrought by Hurricane Maria on Puerto Rico has crippled the island's drug production capabilities and could lead to shortages in medicines and medical devices. "We are aware of several other instances where we may soon face critical shortages if we don’t find a path for removal or ways to get production back up and running," Gottlieb said in a statement. "This is both a short- and long-term issue. We need to ensure access to these critical treatments for the Americans who need them, but also recognize the important role that the medical product industry plays in helping Puerto Rico sustain its economy and help in its recovery." (Fortune)

THE BIG PICTURE

Susan Collins adds to official Graham Cassidy opposition. It now appears that Republican Sens. Rand Paul, Ted Cruz, John McCain, and Susan Collins are all opposed to the Graham Cassidy health care bill to repeal Obamacare (at least in its current form), with Collins the latest to put herself down as a hard "no" on the legislation. Collins' opposition likely sinks the bill, which can only lose two GOP votes, although it's possible Senate leadership will hold an accountability vote on it regardless.

REQUIRED READING

The Swiss Also Have a Private Health Care System. But Theirs Works, by Arthur Appleton

How CEOs Are Embracing Idealism, by Adam Lashinsky

CTE Discoverer: We Shouldn't Be Surprised That Aaron Hernandez Had CTE, by Bennet Omalu

What Happens to Cryptocurrency When You Die? by Jeff John Roberts

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

Find past coverage. Sign up for other Fortune newsletters.
About the Authors
By Sy Mukherjee
See full bioRight Arrow Button Icon
By Clifton Leaf
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

wyle
CommentaryTV
What HBO’s ‘The Pitt’ gets right—and wrong—about treating alcohol use disorder
By Jonathan Hunt-GlassmanApril 2, 2026
15 hours ago
cancer
HealthCancer
Cancer’s grim calculus for the young: their insurance status can determine how long they survive
By Rhonda Winegar, Tara Martin, Zhaoli Liu and The ConversationApril 1, 2026
1 day ago
Hungryroot Review 2026: What We Like About This Unique Meal Delivery
Healthmeal delivery
Hungryroot Review 2026: What We Like About This Unique Meal Delivery
By Emily PharesApril 1, 2026
1 day ago
Nutrafol Review 2026: Ingredients, Cost, and Whether It Works
HealthDietary Supplements
Nutrafol Review 2026: Ingredients, Cost, and Whether It Works
By Christina SnyderApril 1, 2026
1 day ago
gen z
CommentaryGen Z
Gen Z is engineering an analog future — and it’s at least a $5 billion opportunity
By Luba KassovaApril 1, 2026
2 days ago
sheryl
HealthLean In
Sheryl Sandberg tapped a 25-year-old to run Lean In. Here’s her plan to close the AI gender gap
By Jacqueline MunisApril 1, 2026
2 days ago

Most Popular

Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech towns
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech towns
By Fortune EditorsApril 2, 2026
21 hours ago
Current price of gold as of April 1, 2026
Personal Finance
Current price of gold as of April 1, 2026
By Fortune EditorsApril 1, 2026
2 days ago
The tax escape map: Billionaires are bolting for Florida from the West Coast and taking billions in tax revenue with them
Real Estate
The tax escape map: Billionaires are bolting for Florida from the West Coast and taking billions in tax revenue with them
By Fortune EditorsApril 2, 2026
21 hours ago
Major 4-day workweek study suggests that when we work 5 days we spend one doing basically nothing
Success
Major 4-day workweek study suggests that when we work 5 days we spend one doing basically nothing
By Fortune EditorsApril 2, 2026
13 hours ago
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strain
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strain
By Fortune EditorsMarch 31, 2026
3 days ago
Deutsche Bank asked AI if it’s true that AI will solve the economy’s inflation problems. The robots answered
Economy
Deutsche Bank asked AI if it’s true that AI will solve the economy’s inflation problems. The robots answered
By Fortune EditorsApril 1, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.